Trident Texofab Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 241.67 million compared to INR 210.29 million a year ago. Revenue was INR 243.08 million compared to INR 212.93 million a year ago. Net income was INR 7.77 million compared to INR 0.157 million a year ago. Basic earnings per share from continuing operations was INR 0.77 compared to INR 0.02 a year ago. Diluted earnings per share from continuing operations was INR 0.77 compared to INR 0.02 a year ago.
For the six months, sales was INR 475.64 million compared to INR 359.34 million a year ago. Revenue was INR 478.34 million compared to INR 363.09 million a year ago. Net income was INR 10.13 million compared to INR 1.69 million a year ago. Basic earnings per share from continuing operations was INR 1.01 compared to INR 0.17 a year ago. Diluted earnings per share from continuing operations was INR 1.01 compared to INR 0.17 a year ago.